Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.

Pharmacogenomics - 1 Jan 2006

Gordon Michael A, Gil Ji, Lu Bo, Zhang Wu, Yang Dongyun, Yun Jim, Schneider Sylke, Groshen Susan, Iqbal Syma, Press Oliver A, Rhodes Katrin, Lenz Heinz-Josef

Abstract excerpt

PURPOSE: Stage II and III adenocarcinoma of the rectum has an overall 5-year survival rate of approximately 50%, and tumor recurrence remains a major problem despite an improvement in local control through chemotherapy and radiation. The efficacy of chemoradiation therapy may be significantly compromised as a result of interindividual variations in clinical response and host toxicity. Therefore, it is imperative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Combined Modality Therapy
Share to Cyclooxygenase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endonucleases

Share to Glutathione S-Transferase pi

Share to Interleukin-8

Share to Rectal Neoplasms

Share to Recurrence

Share to Transforming Growth Factor beta

Source

Identifiers

PMID: 16354126
DOI: 10.2217/14622416.7.1.67

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.PMID 16354126Read ↗

Gene Signature Is Associated with Early Stage Rectal Cancer RecurrenceSemantic proximity Read ↗

12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.Semantic proximity Read ↗

Epidermal Growth Factor Receptor Gene Polymorphisms Predict Pelvic Recurrence in Patients with Rectal Cancer Treated with ChemoradiationSemantic proximity Read ↗

Molecular predictors of treatment resistance and recurrence following neoadjuvant therapy in rectal cancer.Semantic proximity Read ↗

Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancerSemantic proximity Read ↗

Colorectal cancer susceptibility loci as predictive markers of rectal cancer prognosis after surgery.Semantic proximity Read ↗

A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.Semantic proximity Read ↗

Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapy.Semantic proximity Read ↗

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.Semantic proximity Read ↗

Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.Semantic proximity Read ↗

Association between miRNA-binding site polymorphisms in double-strand break repair genes and risk of recurrence in patients with squamous cell carcinomas of the non-oropharynx.Semantic proximity Read ↗

A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.